Advertisement

Lung

, Volume 193, Issue 3, pp 329–334 | Cite as

The Ratio of Free to Bound Desmosine and Isodesmosine May Reflect Emphysematous Changes in COPD

  • Xingjian Liu
  • Shuren Ma
  • Sophie Liu
  • Ming Liu
  • Gerard Turino
  • Jerome Cantor
Article

Abstract

Background

The unique elastin crosslinks, desmosine and isodesmosine (DID) are significantly elevated in blood, urine, and sputum from patients with COPD, and may decline following treatment of the disease. However, the large degree of variance in this biomarker among COPD patients with similar levels of disease suggests that it has limited prognostic value with regard to the degree of lung disease in a given individual. As an alternative to measuring the total amount of DID, we propose using the ratio of free to peptide-bound DID, which may provide a better indication of overall lung disease.

Methods

To test this hypothesis, the free/bound DID ratio was measured in bronchoalveolar lavage fluid (BALF) from both hamsters with elastase-induced emphysema and controls not given the enzyme, using a combination of liquid chromatography and tandem mass spectroscopy. This ratio was then correlated with airspace enlargement, as measured by the mean percentage of lung surface area at ×100 microscopic magnification.

Results

There was a significant negative correlation between the free/bound DID ratio in BALF and lung surface area. However, there was no correlation between this ratio and total BALF DID, suggesting that free/bound DID is unrelated to the immediate rate of breakdown of elastic fibers, and may instead measure the cumulative effect of elastase injury in the lung.

Conclusions

The free/bound DID ratio may be a useful measure of emphysematous changes in the lung and might also serve as a screening procedure for healthy smokers and other individuals at risk for developing COPD.

Keywords

COPD Emphysema Elastic fibers Desmosine Percolation theory 

Notes

Conflict of interest

None of the authors has a conflict of interest with regard to the material included in this paper.

References

  1. 1.
    Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4:435–459CrossRefPubMedGoogle Scholar
  2. 2.
    Barnes PJ (2003) New concepts in chronic obstructive pulmonary disease. Annu Rev Med 54:113–129CrossRefPubMedGoogle Scholar
  3. 3.
    Tuder RM, Petrache I (2012) Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 122:2749–2755CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Turino GM, Lin YY, He J et al (2012) Elastin degradation: an effective biomarker in COPD. COPD 9:435–438PubMedGoogle Scholar
  5. 5.
    Lindberg CA, Engström G, de Verdier MG et al (2012) Total desmosines in plasma and urine correlate with lung function. Eur Respir J 39:839–845CrossRefPubMedGoogle Scholar
  6. 6.
    Ma S, Turino GM, Lin YY (2011) Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. J Chromatogr B 879:1893–1898CrossRefGoogle Scholar
  7. 7.
    Fregonese L, Ferrari F, Fumagalli M et al (2011) Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antitrypsin deficiency-related COPD. COPD 8:329–333CrossRefPubMedGoogle Scholar
  8. 8.
    Luisetti M, Ma S, Iadarola P et al (2008) Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 32:1146–1157CrossRefPubMedGoogle Scholar
  9. 9.
    Ma S, Lin YY, Turino GM (2007) Measurements of desmosine and isodesmosine by mass spectrometry in COPD. Chest 131:1363–1371CrossRefPubMedGoogle Scholar
  10. 10.
    Stauffer D, Aharony A (2001) Introduction to percolation theory, 2nd edn (revised). Taylor and Francis, PhiladelphiaGoogle Scholar
  11. 11.
    Cantor JO, Ma SM, Turino GM (2013) What percolation theory can tell us about COPD. Med Hypotheses 81:152–155CrossRefPubMedGoogle Scholar
  12. 12.
    Li B, Daggett V (2002) Molecular basis for the extensibility of elastin. J Muscle Res Cell Motil 23:561–573CrossRefPubMedGoogle Scholar
  13. 13.
    Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115:2817–2828PubMedGoogle Scholar
  14. 14.
    Bunde A, Kantelhart JW (2005) Diffusion and conduction in percolation systems. In: Heitjans P, Karger J (eds) Diffusion in condensed matter. Springer, Berlin, pp 895–914CrossRefGoogle Scholar
  15. 15.
    Redner S (2009) Fractal and multifractal scaling of electrical conduction in random resistor networks. In: Meyers PA (ed) Encyclopedia of complexity and systems science. Springer, Berlin, pp 3737–3754CrossRefGoogle Scholar
  16. 16.
    Sander LM, Warren CP, Sokolov IM et al (2002) Percolation on heterogeneous networks as a model for epidemics. Math Biosci 180:293–305CrossRefPubMedGoogle Scholar
  17. 17.
    Sahimi M (2009) Percolation phase transition. In: Meyers PA (ed) Encyclopedia of complexity and systems science. Springer, Berlin, pp 6538–6545CrossRefGoogle Scholar
  18. 18.
    Suki B, Bates JH (2011) Lung tissue mechanics as an emergent phenomenon. J Appl Physiol 110:1111–1118CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Bates JH, Davis GS, Majumdar A et al (2007) Linking parenchymal disease progression to changes in lung mechanical function by percolation. Am J Respir Crit Care Med 176:617–623CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Murphy KD, Hunt GW, Almond DP (2006) Evidence of emergent scaling in mechanical systems. Philos Mag 86:3325–3338CrossRefGoogle Scholar
  21. 21.
    Jesudason R, Black L, Majumdar A et al (2007) Differential effects of static and cyclic stretching during elastase digestion on the mechanical properties of extracellular matrices. J Appl Physiol 103:803–811CrossRefPubMedGoogle Scholar
  22. 22.
    Doyle TJ, Pinto-Plata V, Morse D et al (2012) The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases. Chest 142:1027–1034CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Rosenberg SR, Kalhan R (2012) Biomarkers in chronic obstructive pulmonary disease. Transl Res 159:228–237CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Xingjian Liu
    • 1
  • Shuren Ma
    • 2
  • Sophie Liu
    • 1
  • Ming Liu
    • 3
  • Gerard Turino
    • 2
  • Jerome Cantor
    • 1
    • 4
  1. 1.St John’s UniversityNew YorkUSA
  2. 2.St Luke’s-Roosevelt Hospital CenterNew YorkUSA
  3. 3.Brookdale Medical CenterNew YorkUSA
  4. 4.Department of Pharmaceutical SciencesSt John’s UniversityQueensUSA

Personalised recommendations